Lodo Therapeutics

OverviewSuggest Edit

Lodo Therapeutics Corporation is a drug discovery and development company focused on the creation of naturally derived novel therapeutics that will have a dramatic impact human health on a global basis. Lodo seeks to work in partnership with global pharmaceutical companies and world leading Non-Governmental Organizations (NGO’s) to tackle some of the greatest challenges in human health: resistant infectious disease and cancers. Lodo Therapeutics was created to pursue the scientific vision of Dr. Sean Brady at Rockefeller University. Dr. Brady and his laboratory have developed a genome-based, culture-independent platform for the discovery, biosynthesis, and characterization of small molecules from microbial sources present in soil samples. Lodo believes that the potential cures for a number of deadly and/or debilitating diseases literally lie at our feet. By combining the advancements in DNA sequencing and bioinformatics, this innovative discovery platform exploits the power of microbial evolution for the identification of therapeutically valuable pharmaceutical products derived from natural sources. Lodo Therapeutics, an Accelerator Corporation-backed entity, is headquartered in New York City. The company’s lab and offices are located in the Alexandria Center for Life Science, New York City’s first and only premier life science park.
HQNew York, US

Recent NewsAll News

Latest Updates

Employees (est.) (Sept 2020)33(+7%)
Cybersecurity ratingBMore

Key People/Management at Lodo Therapeutics

Steve Colletti

Steve Colletti

Senior Vice President, R&D
Brad Hover

Brad Hover

Director of Research
Sean Brady

Sean Brady

Academic Advisor
Barbara Dalton

Barbara Dalton

Pfizer Ventures
Johnston Erwin

Johnston Erwin

Eli Lilly and Company
Steve Gillis

Steve Gillis

ARCH Venture Partners
Show more

Lodo Therapeutics Office Locations

Lodo Therapeutics has an office in New York
New York, US (HQ)
430 E 29th St #845
Show all (1)

Lodo Therapeutics Financials and Metrics

Summary Metrics

Founding Date


Lodo Therapeutics total Funding

$17 m

Lodo Therapeutics latest funding size

$17 m

Time since last funding

5 years ago

Lodo Therapeutics investors

Lodo Therapeutics's latest funding round in January 2016 was reported to be $17 m. In total, Lodo Therapeutics has raised $17 m
Show all financial metrics

Lodo Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Lodo Therapeutics Online and Social Media Presence

Embed Graph

Lodo Therapeutics Blogs

Tackling Cancer Metastasis with Engineered Blood Platelets

When cancer cells spread to new parts of the body in a process called metastasis, they often get there by traveling through the bloodstream. To avoid alerting the immune system and possibly triggering their demise, cancer cells coax circulating blood platelets to glom onto their surfaces and mask th…

Masks Save Lives

Reminding others that “masks save lives” isn’t just sound advice. It’s a scientific fact that wearing one in public can help to slow the spread of SARS-CoV-2, the virus responsible for COVID-19.

See the Human Cardiovascular System in a Whole New Way

Watch this brief video and you might guess you’re seeing an animated line drawing, gradually revealing a delicate take on a familiar system: the internal structures of the human body. But this movie doesn’t capture the work of a talented sketch artist. It was created using the first 3D, full-body im…

Building a Better Bacterial Trap for Sepsis

Spiders spin webs to catch insects for dinner. It turns out certain human immune cells, called neutrophils, do something similar to trap bacteria in people who develop sepsis, an uncontrolled, systemic infection that poses a major challenge in hospitals.

A New View of the 3D Genome

This lush panoply of color might stir up daydreams of getting away to explore a tropical rain forest. But what you see here is a new model that's enabling researchers to explore something equally amazing: how a string of DNA that measures 6 feet long can be packed into the microscopic nucleus of a h…
Show more

Lodo Therapeutics Frequently Asked Questions

  • When was Lodo Therapeutics founded?

    Lodo Therapeutics was founded in 2016.

  • Who are Lodo Therapeutics key executives?

    Lodo Therapeutics's key executives are Steve Colletti, Brad Hover and Sean Brady.

  • How many employees does Lodo Therapeutics have?

    Lodo Therapeutics has 33 employees.

  • Who are Lodo Therapeutics competitors?

    Competitors of Lodo Therapeutics include Cannabis Sativa, Endologix and Immunic.

  • Where is Lodo Therapeutics headquarters?

    Lodo Therapeutics headquarters is located at 430 E 29th St #845, New York.

  • Where are Lodo Therapeutics offices?

    Lodo Therapeutics has an office in New York.

  • How many offices does Lodo Therapeutics have?

    Lodo Therapeutics has 1 office.